MEDIUM confidence: 100% data completeness, but the composite (48) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Net insider -$96.3M over 180 days (0 open-market buys, 53 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
| Metric (USD) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $17.2B— | $17.4B+1.2% | $14.9B-14.5% | $18.4B+23.7% | $23.2B+26.0% |
| EPS (dil.) | $3.27— | $3.32+1.5% | $2.90-12.7% | $4.15+43.1% | $5.76+38.8% |
| Free Cash Flow | $2.6B— | $4.7B+83.2% | $4.3B-9.0% | $5.4B+27.2% | $4.9B-9.7% |
| Gross Margin | 45.7% | 44.6%-1.1pp | 47.3%+2.7pp | 48.7%+1.4pp | 50.5%+1.8pp |
| Operating Margin | 31.2% | 29.7%-1.5pp | 28.6%-1.1pp | 32.0%+3.4pp | 35.3%+3.3pp |
| Net Margin | 26.7% | 25.9%-0.8pp | 25.7%-0.2pp | 29.1%+3.4pp | 31.3%+2.2pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Avg target $405 (last qtr, 19 analysts) → $339 (last mo, 5) (-16.4%).
Buy-rated share 78% → 86% over ~3 months (+7pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | $1.69 | $1.82 | +7.7% |
| Apr 2026 | $1.36 | $1.47 | +8.1% |
| Jan 2026 | $1.17 | $1.27 | +8.5% |
| Oct 2025 | $1.22 | $1.26 | +3.3% |
| Jul 2025 | $1.21 | $1.33 | +9.9% |
| Apr 2025 | $1.00 | $1.04 | +4.0% |
| Jan 2025 | $0.88 | $0.91 | +3.6% |
| Oct 2024 | $0.81 | $0.86 | +6.2% |
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 12.7%/yr (revenue basis).
Base free cash flow $4.9B (avg FY2024–FY2026; latest year $4.9B) · equity value $415.0B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
Lam Research Corporation's QScore of 48 indicates a neutral outlook, with the stock's short-term score slightly exceeding its long-term score. The company scores high on momentum and profitability, driven by its strong 12-month return of 213.5% and high ROE of 67.0%. However, its value score is dragged down by a high P/E of 57.3, indicating the stock trades at a premium. The growth score is also mixed, with strong revenue and EPS growth offset by a decline in free cash flow growth.